How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Cursor IDE zero-day vulnerability: AI security firm Mindgard spent seven months trying to report a Windows code-execution ...

Singapore's Minister for Health Ong Ye Kung has called on governments and industry to take a deliberate, humanistic stance on ...

As they scramble to keep their systems online, AI companies are making things expensive for the rest of us. Large language ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

OpenAI’s expanding robotics and simulation efforts signal that embodied AI is becoming the next frontier, strengthening the ...

Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

I know I’m old because I remember when a B+ was a respectable grade. Now it’s more like an indictment. I’m a masochist if I ...

This past summer has seen major updates in the burgeoning relationship between the U.S. government and developers of the ...

On the evening of July 10, AI investor Matt Shumer posted a terse, furious message to X: GPT-5.6 Sol had just accidentally deleted nearly all the files on his Mac ...

A tech CEO argues that critics of AI are failing to weigh both sides of a historic shift, one that could eliminate cancer, ...